Please provide your email address to receive an email when new articles are posted on . Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral ...
ATLANTA--(BUSINESS WIRE)-- According to THE SAGE GROUP, almost 70% of the procedures performed to treat Peripheral Artery Disease (PAD) were endovascular (angioplasty, atherectomy and primary stenting ...
NATICK, Mass. and SAN FRANCISCO, Boston Scientific Corporation welcomed positive outcomes from the COBRA clinical trial, which evaluated post-dilation of nitinol stents using CryoPlasty® Therapy with ...
(MENAFN- iCrowdNewsWire) The global Peripheral Stent Implants Market is expected to stimulate at a good rate In Upcoming Years. Virtual consultations are amongst the ongoing trends. They mitigate the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio LAS VEGAS — A repuncturable vascular ...
The FiberNet Embolic Protection System is a temporary, intravascular, 0.014-inch wire-based filter system that is placed distal to a lesion to be treated by interventional procedures (Figures 1 & 2).
NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...
Abbott has collected a green light in Europe for its dissolving, drug-laden stent in peripheral artery disease, following its approval from the FDA early last year. The company said the CE mark opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results